Comparative study of CD34, α-SMA and h-caldesmon expression in the stroma of gynaecomastia and male breast carcinoma

Histopathology

Volumn 47, Issue 1, 2005, Pages 74-81

  Kalekou, H ^a   Kostopoulos, I ^b   Milias, S ^b   Papadimitriou, Constantine S ^b,c  

^a Saint Paul Hospital of Thessaloniki   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c ARISTOTLE UNIVERSITY MEDICAL SCHOOL   (Greece)

Author keywords

Carcinoma; CD34+ fibroblasts; Gynaecomastia; Male breast; Myofibroblasts

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CALDESMON; CD34 ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; BREAST ADENOMA; BREAST CARCINOMA; COMPARATIVE STUDY; DERMATOFIBROSARCOMA PROTUBERANS; GASTROINTESTINAL STROMAL TUMOR; GENE EXPRESSION; GYNECOMASTIA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LIPOMA; MAJOR CLINICAL STUDY; MALE; MALE BREAST; MYOEPITHELIUM CELL; MYOFIBROBLAST; NERVE SHEATH TUMOR; PAPILLARY CARCINOMA; PRIORITY JOURNAL;

ACTINS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD34; BIOLOGICAL MARKERS; BREAST NEOPLASMS, MALE; CALMODULIN-BINDING PROTEINS; GYNECOMASTIA; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUSCLE, SMOOTH;

EID: 22144443180     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2005.02171.x     Document Type: Article

References (35)

1. Lanza F, Healy L, Sutherland DR. Structural and functional features of the CD34 antigen: an update. J. Biol. Regul. Homeost. Agents 2001; 15; 1-13.
2. Bucala R, Spiegel A, Chesney J et al. Circulating fibrocytes define a new leucocyte subpopulation that mediates tissue repair. Mol. Med. 1994; 1; 71-81.
3. Chesney J, Bacher M, Bender A et al. The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive T cells in situ. Proc. Natl Acad. Sci. USA 1997; 94; 6307-6312.
4. Barth PJ, Ebrahimsade S, Hellinger A et al CD34+ fibrocytes in neoplastic and inflammatory pancreatic lesions. Virchows Arch. 2002; 440; 128-133.
5. Barth PJ, Ramaswamy A, Moll R. CD34+ fibrocytes in normal cervical stroma, cervical intraepithelial neoplasia III and invasive squamous cell carcinoma of the cervix uteri. Virchows Arch. 2002; 441; 564-568.
6. Nakayama H, Enzan H, Miyazaki E et al. Differential expression of CD34 in normal colorectal tissue, peritumoral inflammatory tissue and tumour stroma. J. Clin. Pathol. 2000; 53; 626-629.
7. Nakayama H, Naruse K, Miyazaki E et al. The specific distribution of dendritic interstitial cells at the tumor border of major salivary gland pleomorphic adenomas. Mod. Pathol. 1999; 12; 445-449.
8. Schurch W, Seemayer TA, Gabbiani G. Myofibroblast. In Sternberg SS ed. Histology for pathologists. Philadelphia: Lipincott Williams & Wilkins, 1992; 109-144.
9. Soma L, LiVolsi VA, Baloch ZW. Dendritic interstitial and myofibroblastic cells at the border of salivary gland tumors. Arch. Pathol. Lab. Med. 2001; 125; 232-236.
10. Swanson PE, Fitzpatrick MM, Ritter JH et al. Immunohistologic differential diagnosis of basal cell carcinoma, squamous cell carcinoma and trichoepithelioma in small cutaneous biopsy specimens. J. Cutan. Pathol. 1998; 25; 153-159.
11. Barth PJ, Ebrahimsade R, Ramaswamy A et al. CD34+ fibrocytes in invasive ductal carcinoma, ductal carcinoma in situ and benign breast lesions. Virchows Arch. 2002; 440; 298-303.
12. Chauhan H, Abraham A, Phillips JR et al. There is more than one kind of myofibroblast: analysis of CD34 expression in benign, in situ, and invasive breast lesions. J. Clin. Pathol. 2003; 56; 271-276.
13. Chen CM, Chen CJ, Chang CL et al. CD34, CD117 and actin expression in phyllodes tumor of the breast. J. Surg. Res. 2000; 94; 84-91.
14. Moore T, Lee AH. Expression of CD34 and bcl2 in phyllodes tumours, fibroadenomas and spindle cell lesions of the breast. Histopathology 2001; 38; 62-67.
15. Milanezi MF, Saggioro FP, Zanati SG et al. Pseudoangiomatous hyperplasia of mammary stroma associated with gynaecomastia. J. Clin. Pathol 1998; 51; 204-206.
16. Yamazaki K, Eyden BP. Ultrastructural and immunohistochemical observations on intralobular fibroblasts of human breast with observations on the CD34 antigen. J. Submicrosc. Cytol. Pathol 1995; 27; 309-323.
17. Ramaswamy A, Moll R, Barth PJ. CD34+ fibrocytes in tubular carcinomas and radial scars of the breast. Virchows Arch. 2003; 443; 536-540.
18. Magro G, Michal M, Bisceglia M. Benign spindle cell tumours of the mammary stroma: diagnostic criteria, classification, and histogenesis. Pathol. Res. Pract. 2001; 197; 453-456.
19. Kostopoulos I, Barbanis S, Kalekou H et al. Male breast carcinoma of the papillary solid variant with unique CD34 positivity. Virchows Arch. 2003; 443; 591-593.
20. Weiss SW, Goldblum JR. Immunohistochemistry for analysis of soft tissue tumors. In Strauss M ed. Enzinger and Weiss's soft tissue tumors. St Louis, MO: Mosby Inc., 2001; 22.
21. Magro G, Bisceglia M, Michal M et al. Spindle cell lipoma-like tumor, solitary fibrous tumor and myofibroblastoma of the breast: a clinicopathological analysis of 13 cases in favor of a unifying histogenetic concept. Virchows Arch. 2002; 440; 249-260.
22. Sobue K, Seller JR. Caldesmon: a novel regulatory protein in smooth and non smooth actomyosin system. J. Biol. Chem. 1991; 266; 12115-12118.
23. Ceballos KM, Nielsen GP, Selig MK et al. Is anti-h-caldesmon useful in distinguishing smooth muscle and myofibroblastic tumors? An immunohistochemical study. Am. J. Clin. Pathol 2000; 114; 746-753.
24. Magro G, Currera A, Bisceglia M. H-caldesmon expression in myofibroblastoma of the breast: evidence supporting the distinction from leiomyoma. Histopathology 2003; 42; 233-238.
25. Bannayan GA, Hajdu SI. Gynaecomastia. Clinicopathologic study of 351 cases. Am. J. Clin. Pathol 1972; 57; 431-437.
26. Ronnov-Jessen L, Petersen: OW, Bissell MJ. Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. Physiol Rev. 1996; 76; 69-125.
27. Illueca C, Monteagudo C, Revert A et al. Diagnostic value of CD34 immunostaining in desmoplastic trichilemmoma. J. Cutan. Pathol. 1998; 25; 435-439.
28. Kirchmann TT, Prieto VG, Smoller BR. CD34 staining pattern distinguishes basal cell carcinoma from trichoepithelioma. Arch. Dermatol. 1994; 130; 589-592.
29. Kirchmann TT, Prieto VG, Smoller BR. Use of CD34 in assessing the relationship between stroma and tumor in desmoplastic keratinocytic neoplasms. J. Cutan. Pathol. 1995; 22; 422-426.
30. Lanzafame S, Magro G, Colombatti A. Expression and distribution of type VI collagen in gynaecomastia. Acta Histochem. 1994; 96; 219-223.
31. Faouzi S, Le Bail B, Neaud V et al. Myofibroblasts are responsible for collagen synthesis in the stroma of human hepatocellular carcinoma: an in vivo and in vitro study. J. Hepatol. 1999; 30; 275-284.
32. Brittan M, Hunt T, Jeffery R et al. Bone marrow derivation of pericryptal myofibroblasts in the mouse and human small intestine and colon. Gut 2002; 50; 752-757.
33. Basset P, Bellocq JP, Wolf C et al. A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 1990; 348; 699-704.
34. Sternlicht MD, Lochter A, Sympson CJ et al. The stromal proteinase MMP3/stromelysin-I promotes mammary carcinogenesis. Cell 1999; 98; 137-146.
35. Nielsen HL, Ronnov-Jessen L, Villadsen R, Petersen OW. Identification of EPSTI1, a novel gene induced by epithelial-stromal interaction in human breast cancer. Genomics 2002; 79; 703-710.